Processa Pharmaceuticals, Inc. (PCSA) financial statements and ratios from SEC XBRL: revenue $109491.00 (TTM), net margin -12388.1%, revenue growth -45.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $109491.00 |
| Net Margin | -12388.1% |
| Revenue Growth (YoY) | -45.6% |
| EPS Growth (YoY) | 167.7% |
| Price / Sales | 140.70 |
| Altman Z-Score | -21.93 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PCSA overview · PCSA earnings · PCSA KPIs · PCSA investor relations · PCSA ownership · PCSA peers · PCSA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.